Sanofi's 4-in-1 influenza vaccine joins GlaxoSmithKline's Fluarix Quadrivalent and AstraZeneca's MedImmune FluMist Quadrivalent that are already approved for use in the United States. MSD and ...
This week, MedImmune celebrates its 25th anniversary – and has come to represent half of AstraZeneca’s research and development pipeline. Best known, perhaps, as the maker of FluMist ...
Tim has published more than a dozen Kellogg case studies including Crestor, MedImmune: FluMist Introduction and Genzyme: the Synvisc-One Investment Decision. In a competitive market, brands have ...
Some results have been hidden because they may be inaccessible to you